Sector valuations MannKind Corporation

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 10/03/2026 GMT			5-day change	1st Jan Change
2.610 ^USD	-2.61%		-10.77%	-53.97%

03-05	MannKind Reports Convertible Notes Settlement	MT
03-05	Wedbush Adjusts Price Target on MannKind to $8 From $10, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
MANNKIND CORPORATION	-417.6x	-	3.18x	-	-	-	-	804M
ARGENX SE	43.19x	6.77x	2.1x	10.11x	36.48x	37.2x	0.03%	45.56B
WUXI APPTEC CO., LTD.	16.15x	3.9x	0.21x	5.76x	12.69x	13.87x	1.85%	40.81B
INSMED INCORPORATED	-53.49x	93.4x	0.92x	18.02x	-59.54x	-58.71x	-.--%	31.01B
BIONTECH SE	-16.58x	1x	2.2x	2.76x	-13.85x	-4.56x	-.--%	21.05B
WUXI BIOLOGICS (CAYMAN) INC.	28.08x	2.75x	0.6x	5.79x	16.09x	19.89x	-.--%	19.37B
GENMAB A/S	22.45x	2.64x	-1.25x	4.26x	13.93x	15.83x	-.--%	17.15B
AKESO, INC.	-329.86x	11.84x	6.74x	27.4x	1508.36x	-330.88x	-.--%	13.54B
SUMMIT THERAPEUTICS INC.	-14.37x	62.88x	0.69x	6424.77x	-18.36x	-13.86x	-.--%	12.66B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-172.74x	19.08x	-2.01x	42.14x	-167.37x	-152.68x	-.--%	12.33B
EXELIXIS, INC.	13.5x	3.48x	1.35x	3.75x	8.9x	10.01x	-.--%	10.72B
MADRIGAL PHARMACEUTICALS, INC.	-85.77x	16.43x	1.41x	6.32x	-94.47x	-65.2x	-.--%	9.93B
IMMUNITYBIO, INC.	-29.13x	-	1.05x	-	-	-	-	8.24B
VAXCYTE, INC.	-7.89x	-	-0.25x	-	-6.99x	-6.78x	-.--%	8.38B
ARROWHEAD PHARMACEUTICALS, INC.	-17.13x	15.42x	-0x	16.51x	-23.48x	-16.54x	-.--%	8.29B
NUVALENT, INC.	-17.99x	6.12x	6.34x	509.09x	-15.71x	-15.87x	-.--%	8.04B
PHARMAESSENTIA CORPORATION	33.47x	6.36x	0.71x	9.68x	24.41x	25.12x	0.25%	7.83B
REMEGEN CO., LTD.	-216.42x	17.05x	2.5x	20.06x	357.18x	-454.91x	-.--%	8.42B
Average	-67.90x	17.94x	1.47x	473.76x	98.64x	-62.38x	0.13%	15.78B
Weighted average by Cap.	-29.65x	19.67x	1.27x	331.14x	75.24x	-36.47x	0.29%